Stay updated on ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record now displays details for the completed Phase 1/2 ARV-110 trial in patients with metastatic castration-resistant prostate cancer, including its study plan, eligibility criteria, outcomes, and 54 U.S. locations. It also shows the study is no longer recruiting participants.SummaryDifference71%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe error page’s footer now shows site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check62 days agoChange DetectedThe study page now renders a 403 Forbidden error page (with a basic header and navigation), replacing the previously visible trial details and related information.SummaryDifference18%

Stay in the know with updates to ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page.